Search results for "Antifungal drug"

showing 10 items of 22 documents

Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients

2016

Background Invasive fungal infections are important causes of morbidity and mortality among critically ill patients. Early institution of antifungal therapy is pivotal for mortality reduction. Starting a targeted antifungal therapy after culture positivity and fungi identification requires a long time. Therefore, alternative strategies (globally defined as 'untargeted antifungal treatments') for antifungal therapy institution in patients without proven microbiological evidence of fungal infections have been discussed by international guidelines. This review was originally published in 2006 and updated in 2016. This updated review provides additional evidence for the clinician dealing with s…

Adultmedicine.medical_specialtyAntifungal drugMycoseintensive care medicinelaw.invention03 medical and health sciencesImmunocompromised Hostcritically ill patient0302 clinical medicineRandomized controlled triallawInternal medicineAmphotericin BmedicineHumansAntifungal AgentPharmacology (medical)030212 general & internal medicineMED/41 - ANESTESIOLOGIAIntensive care medicineFluconazoleFluconazole [therapeutic use]Randomized Controlled Trials as Topicbusiness.industryfungal infectionMicafungin030208 emergency & critical care medicinePublication biasMycoses [mortalityClinical trialCritical Illness [mortality]; Amphotericin B [therapeutic use]; Antifungal Agents [therapeutic use]; Fluconazole [therapeutic use]; Immunocompromised Host; Mycoses [mortality; prevention & control]; Randomized Controlled Trials as Topic; Adult; HumansAntifungal Agents [therapeutic use]prevention & control]Relative riskMeta-analysisAmphotericin B [therapeutic use]AnidulafunginCritical IllneCritical Illness [mortality]businessmedicine.drugHuman
researchProduct

Accumulation of Amphotericin B in Human Macrophages Enhances Activity against Aspergillus fumigatus Conidia: Quantification of Conidial Kill at the S…

1998

ABSTRACT A cytofluorometric assay that allowed assessment of damage to phagocytosed Aspergillus fumigatus conidia at the single-cell level was developed. After ingestion by monocyte-derived macrophages (MDMs), conidia were reisolated by treatment of the cells with streptolysin O, a pore-forming toxin with lytic properties on mammalian cells but not on fungi. The counts obtained by staining of damaged conidia with propidium iodide and quantification by cytofluorometry correlated with colony counts. By the use of this method, we demonstrate that MDMs differentiated in vitro by low-dose granulocyte-macrophage colony-stimulating factor and gamma interferon have only a limited capacity to damage…

Antifungal AgentsPhagocytosisDetergentsAntifungal drugAspergillus fumigatusMicrobiologychemistry.chemical_compoundPhagocytosisAmphotericin BAmphotericin BmedicineHumansMacrophagePharmacology (medical)Interferon gammaPropidium iodideskin and connective tissue diseasesMechanisms of Action: Physiological EffectsPharmacologyAspergillusbiologyAspergillus fumigatusMacrophagesGranulocyte-Macrophage Colony-Stimulating FactorFlow Cytometrybiology.organism_classificationInfectious Diseaseschemistrymedicine.drugAntimicrobial Agents and Chemotherapy
researchProduct

Inhibition of Filamentation Can Be Used To Treat Disseminated Candidiasis

2006

ABSTRACT Candida albicans remains the leading causative agent of invasive fungal infection. Although the importance of filamentation in C. albicans pathogenesis has been extensively investigated, in vivo studies to date have been unable to dissect the role of this developmental process in the establishment of infection versus the development of active disease as characterized by damage to the host leading to mortality. To address this issue, we genetically engineered a C. albicans tet-NRG1 strain in which filamentation and virulence can be modulated both in vitro and in vivo simply by the presence or absence of doxycycline (DOX): this strain enabled us, in a prior study, to demonstrate that…

Antifungal AgentsSaccharomyces cerevisiae ProteinsHyphaeAntifungal drugVirulenceKidneyMicrobiologyMiceFilamentationIn vivoGene Expression Regulation FungalCandida albicansmedicineAnimalsExperimental TherapeuticsPharmacology (medical)Candida albicansPharmacologyDoxycyclineMice Inbred BALB CVirulencebiologyCandidiasisDisseminated Candidiasisbiology.organism_classificationCorpus albicansDNA-Binding ProteinsRepressor ProteinsInfectious DiseasesDoxycyclineFemaleGenetic Engineeringmedicine.drugAntimicrobial Agents and Chemotherapy
researchProduct

Antifungal activity and tautomeric cyclization equilibria of formylphenylboronic acids

2019

2-Formylphenylboronic acid and four isomeric fluoro-2-formylphenylboronic acids have been found active against a series of fungal strains: Aspergillus, Fusarium, Penicillium and Candida. The level of antifungal activity was evaluated by agar diffusion tests as well as the determination of minimum inhibitory concentrations (MICs) by serial dilution method. Among the tested compounds, 4-fluoro-2-formylphenylboronic acid - an analogue of the known antifungal drug Tavaborole (AN2690) - proved to be the most potent antifungal agent. The tautomeric equilibrium leading to the formation of 3-hydroxybenzoxaboroles as well as the position of the fluorine substituent were revealed to play a crucial ro…

Antifungal Agentsfood.ingredientSerial dilutionStereochemistryAntifungal drugSubstituentMicrobial Sensitivity TestsFormylphenylboronic acid01 natural sciencesBiochemistryStructure-Activity Relationshipchemistry.chemical_compoundfoodFusariumDrug DiscoveryAgarAntifungal activityTautomerizationMolecular BiologyCandidaAspergillusTavaboroleDose-Response Relationship DrugMolecular Structurebiology010405 organic chemistryChemistryOrganic ChemistryPenicilliumCyclization equilibriaOrganoboron compoundsbiology.organism_classificationBoronic AcidsTautomer0104 chemical sciences010404 medicinal & biomolecular chemistryAspergillusCyclizationPenicilliumBioorganic Chemistry
researchProduct

Synthesis, Properties and Antimicrobial Activity of 5-Trifluoromethyl-2-formylphenylboronic Acid

2020

2-Formylphenylboronic acids display many interesting features, not only from synthetic but also from an application as well as structural points of view. 5-Trifluoromethyl-2-formyl phenylboronic acid has been synthesized and characterized in terms of its structure and properties. The presence of an electron-withdrawing substituent results in a considerable rise in the acidity in comparison with its analogues. In some solutions, the title compound isomerizes with formation of the corresponding 3-hydroxybenzoxaborole. Taking into account the probable mechanism of antifungal action of benzoxaboroles, which blocks the cytoplasmic leucyl-tRNA synthetase (LeuRS) of the microorganism, docking stud…

Antifungal AgentstrifluoromethylStereochemistryphenylboronicBacillus cereusAntifungal drugbenzoxaborolePharmaceutical ScienceMicrobial Sensitivity Tests010402 general chemistry01 natural sciencesequilibriumArticleAnalytical Chemistrycrystallcsh:QD241-441chemistry.chemical_compoundTavaborolelcsh:Organic chemistryCandida albicansDrug DiscoveryEscherichia colimedicineformylPhysical and Theoretical ChemistryPhenylboronic acidCandida albicansacidityTrifluoromethylKerydinbiology010405 organic chemistryChemistryOrganic ChemistryActive sitebiology.organism_classificationBoronic AcidsAnti-Bacterial Agents0104 chemical sciencesMechanism of actionChemistry (miscellaneous)Docking (molecular)Benzaldehydesdockingbiology.proteinMolecular MedicineantimicrobialLeucine-tRNA Ligasemedicine.symptomMolecules
researchProduct

Mechanochemical synthesis of antifungal bis(benzoxaboroles)

2020

Several piperazine bis(benzoxaboroles) have been obtained both in solution as well as in the solid state. The environmentally friendly mechanochemical approach – hitherto not applied for the preparation of benzoxaboroles – was particularly beneficial in the case of two products afforded in low yields in solution. The in vitro studies showed high potential of the studied bis(fluorobenzoxaboroles) as antifungal agents, highlighting also the influence of the fluorine substituent position on their microbiological activity. The highest activity against A. niger, A. terreus, P. ochrochloron, C. tenuis and C. albicans was displayed by the analogue of the known benzoxaborole antifungal drug Kerydin…

AntifungalTavaborolemedicine.drug_classGeneral Chemical EngineeringAntifungal drugSubstituentSolid-stateGeneral ChemistryCombinatorial chemistryEnvironmentally friendlychemistry.chemical_compoundPiperazinechemistrymedicineHigh potentialRSC Advances
researchProduct

Role of the Non-Canonical RNAi Pathway in the Antifungal Resistance and Virulence of Mucorales

2021

Mucorales are the causal agents for the lethal disease known as mucormycosis. Mortality rates of mucormycosis can reach up to 90%, due to the mucoralean antifungal drug resistance and the lack of effective therapies. A concerning urgency among the medical and scientific community claims to find targets for the development of new treatments. Here, we reviewed different studies describing the role and machinery of a novel non-canonical RNAi pathway (NCRIP) only conserved in Mucorales. Its non-canonical features are the independence of Dicer and Argonaute proteins. Conversely, NCRIP relies on RNA-dependent RNA Polymerases (RdRP) and an atypical ribonuclease III (RNase III). NCRIP regulates the…

AntifungalTransposable element0301 basic medicineMucoralesAntifungal Agentstransposonmedicine.drug_classRNA Stability030106 microbiologyAntifungal drugVirulenceReviewQH426-470mucormycosis03 medical and health sciencesDrug Resistance FungalRNA interferenceFongsmedicineGeneticsbiochemistryRNA MessengerRibonuclease IIIepimutantGenetics (clinical)Genome stabilityGeneticsRdRPR3B2biologyMucormycosisnon-canonical RNAiRNA FungalArgonauteantifungal resistancemedicine.diseasebiology.organism_classificationvirulenceRNA silencing030104 developmental biologyNon canonicalbiology.proteinInfeccióMucoralesRNA Interferencegenome stabilitySignal TransductionDicerGenes
researchProduct

The influence of fluorine position on the properties of fluorobenzoxaboroles

2015

5-Fluoro-2,1-benzoxaborol-1(3H)-ol, a potent antifungal drug also known as Tavaborole or AN2690, has been compared with its three isomers in terms of its activity against several fungi as well as pKa and multinuclear NMR characterization. The molecular and crystal structure of 6-fluoro-2,1-benzoxaborol-1(3H)-ol was determined and compared with that of AN2690.

Boron CompoundsModels Molecularcrystal structureAntifungal AgentsMagnetic Resonance SpectroscopyHalogenationStereochemistryAntifungal drugchemistry.chemical_elementCrystal structureCrystallography X-RayBiochemistrybenzoxaborolesIsomerismDrug DiscoveryHumansMolecular BiologytavaboroleTavaboroleChemistryOrganic Chemistryantifungal activityFungiFluorineBridged Bicyclo Compounds HeterocyclicMycosesFluorineBioorganic Chemistry
researchProduct

Current treatment of oral candidiasis: a literature review

2014

Candidiasis or oral candidosis is one of the most common human opportunistic fungal infections of the oral cavity. This pathology has a wide variety of treatment which has been studied until these days. The present study offers a literature review on the treatment of oral candidiasis, with the purpose of establish which treatment is the most suitable in each case. Searching the 24 latest articles about treatment of candidiasis it concluded that the incidence depends on the type of the candidiasis and the virulence of the infection. Although nystatin and amphotericin b were the most drugs used locally, fluconazole oral suspension is proving to be a very effective drug in the treatment of ora…

Drugmedicine.medical_specialtyOral Medicine and Pathologybusiness.industryItraconazolemedia_common.quotation_subjectAntifungal drugsIncidence (epidemiology)ResearchOdontologíaPharmacology:CIENCIAS MÉDICAS [UNESCO]DermatologyCiencias de la saludNystatinAmphotericin BUNESCO::CIENCIAS MÉDICASmedicineKetoconazolebusinessGeneral DentistryFluconazolemedia_commonmedicine.drug
researchProduct

Impact of glucuronide interferences on therapeutic drug monitoring of posaconazole by tandem mass spectrometry.

2010

Abstract Background: Posaconazole is a novel antifungal drug for oral application intended especially for therapy of invasive mycoses. Due to variable gastrointestinal absorption, adverse side effects, and suspected drug-drug interactions, therapeutic drug monitoring (TDM) of posaconazole is recommended. Method: A fast ultra performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) method for quantification of posaconazole with a run-time <3 min was developed and compared to a LC-MS/MS method and HPLC method with fluorescence detection. Results: During evaluation of UPLC-MS/MS, two earlier eluting peaks were observed in the MRM trace of posaconazole. This was only seen in p…

Observer VariationPosaconazoleElectrosprayChromatographyAntifungal Agentsmedicine.diagnostic_testChemistryBiochemistry (medical)Clinical BiochemistryAntifungal drugGeneral MedicineTriazolesMass spectrometryTandem mass spectrometryHigh-performance liquid chromatographyGlucuronidesTherapeutic drug monitoringTandem Mass SpectrometrymedicineHumansDrug MonitoringGlucuronidemedicine.drugClinical chemistry and laboratory medicine
researchProduct